Digitisation | April 05, 2022
Feedback Medical brings Bleepa to India
Announces pilot project for rapid, remote diagnosis of tuberculosis
Announces pilot project for rapid, remote diagnosis of tuberculosis
CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
In May 2021, Daiichi Sankyo had submitted a supplemental new drug application (sNDA) for Tarlige tablets based on results from a phase 3 trial in patients with CNP
Evusheld significantly reduced the risk of developing symptomatic COVID-19 in PROVENT Phase III trial, with protection lasting at least six months
Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy
A staggering 65% of the TB cases in India are in the 15-45 age group
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
Data to establish the safety profile and human dose of vaccine candidate
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
Subscribe To Our Newsletter & Stay Updated
